BHC.TO实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (30 Apr 2024 @ 01:46):

Stats
今日成交量	109 670
平均成交量	371 546
市值	4.38B
EPS	$0 ( 2024-02-21 )
下一个收益日期	( $0.940 ) 2024-05-01
Last Dividend	$0.0970 ( 2010-08-30 )
Next Dividend	$0 ( N/A )
P/E	-5.40
ATR14	$0.0100 (0.08%)

音量相关性

長: -0.15 (neutral)

短: 0.33 (neutral)

Signal:(63.034) Neutral

BAUSCH HEALTH COMPANIES 相关性

10 最正相关
HOM-UN.TO	0.907
CJR-B.TO	0.898
MTY.TO	0.893
GOOS.TO	0.885
ERO.TO	0.882
LUN.TO	0.88
LB.TO	0.877
CARS.TO	0.875
IGM.TO	0.872
D-UN.TO	0.871

10 最负相关
QBTL.TO	-0.877
UNS.TO	-0.87
SBB.TO	-0.855
E.TO	-0.844
ABCT.TO	-0.836
SFC.TO	-0.822
THNC.TO	-0.822

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

BAUSCH HEALTH COMPANIES 相关性 - 货币/商品

0.51
( weak )

0.27
( neutral )

0.00
( neutral )

-0.41
( neutral )

0.14
( neutral )

0.60
( weak )

BAUSCH HEALTH COMPANIES 财务报表

Annual	2023
营收:	$8.76B
毛利润:	$6.20B (70.78 %)
EPS:	$-1.620

FY	2023
营收:	$8.76B
毛利润:	$6.20B (70.78 %)
EPS:	$-1.620

FY	2022
营收:	$8.12B
毛利润:	$5.76B (70.90 %)
EPS:	$-0.590

FY	2021
营收:	$8.43B
毛利润:	$6.04B (71.61 %)
EPS:	$-2.64

Financial Reports:

No articles found.

BAUSCH HEALTH COMPANIES Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

BAUSCH HEALTH COMPANIES Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 4.74 - low (57.34%) | Divividend Growth Potential Score: 3.23 - No dividend growth expected in the near future

Information

First Dividend	$0.598	2005-11-28
Last Dividend	$0.0970	2010-08-30
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	20	--
Total Paid Out	$5.49	--
Avg. Dividend % Per Year	0.00%	--
Score	2.9	--
Div. Sustainability Score	4.74
Div.Growth Potential Score	3.23
Div. Directional Score	3.98	--

Next Divdend (Est)
(2024-08-05)

$0 Estimate 0.00 %

Dividend Stability

0.05 Very Bad

Dividend Score

2.90

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2005	$0	0.00%
2006	$0	0.00%
2007	$0	0.00%
2008	$0	0.00%
2009	$0	0.00%
2010	$0	0.00%
2011	$0	0.00%
2012	$0	0.00%
2013	$0	0.00%
2014	$0	0.00%
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$0	0.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for TSX

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
XFF.TO	Dividend Junior	2023-09-25	Quarterly	10	2.28%
PPL.TO	Dividend King	2023-09-14	Bi-Monthly	22	3.95%
FCSB.TO	Dividend Junior	2023-08-28	Monthly	6	1.28%
ZVU.TO	Dividend Junior	2023-06-28	Quarterly	7	1.27%
TQCD.TO	Dividend Knight	2023-08-29	Monthly	6	2.50%
MCB.TO	Dividend Knight	2023-09-28	Annually	21	0.54%
CSAV.TO	Dividend Knight	2023-08-25	Monthly	6	1.44%
XQB.TO	Dividend Knight	2023-09-25	Monthly	15	1.55%
RBNK.TO	Dividend Knight	2023-08-23	Monthly	8	2.47%
FTS.TO	Dividend Knight	2023-11-16	Quarterly	30	2.58%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.0685	1.500	-1.370	-2.06	[0 - 0.5]
returnOnAssetsTTM	-0.0219	1.200	-0.731	-0.878	[0 - 0.3]
returnOnEquityTTM	0.618	1.500	4.24	6.36	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.301	0.800	8.50	6.80	[1 - 3]
quickRatioTTM	0.685	0.800	-0.679	-0.543	[0.8 - 2.5]
cashRatioTTM	0.220	1.500	9.89	10.00	[0.2 - 2]
debtRatioTTM	0.819	-1.500	10.00	-10.00	[0 - 0.6]
interestCoverageTTM	0.725	1.000	-0.843	-0.843	[3 - 30]
operatingCashFlowPerShareTTM	3.09	2.00	8.97	10.00	[0 - 30]
freeCashFlowPerShareTTM	2.30	2.00	8.85	10.00	[0 - 20]
debtEquityRatioTTM	-21.91	-1.500	-10.00	10.00	[0 - 2.5]
grossProfitMarginTTM	0.708	1.000	1.537	1.537	[0.2 - 0.8]
operatingProfitMarginTTM	0.110	1.000	9.80	9.80	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.0489	1.000	-0.839	-0.839	[0.2 - 2]
assetTurnoverTTM	0.320	0.800	-1.199	-0.959	[0.5 - 2]
Total Score				4.74

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-5.16	1.000	-0.623	0	[1 - 100]
returnOnEquityTTM	0.618	2.50	6.30	6.36	[0.1 - 1.5]
freeCashFlowPerShareTTM	2.30	2.00	9.23	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	3.09	2.00	8.97	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.143	1.500	-4.29	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.125	1.000	9.37	0	[0.1 - 0.5]
Total Score				3.23

BAUSCH HEALTH COMPANIES

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

实时更新： BAUSCH HEALTH COMPANIES [BHC.TO]

Upcoming Earnings Alert

BAUSCH HEALTH COMPANIES Dividend Information - Ex Dividend Junior

Dividend Commentary

Top 10 dividend Companies for TSX

Dividend Sustainability Score (DSS)

Dividend Growth Score (DGS)